NERV - Minerva Neurosciences, Inc. Profit before interest, taxes and amortization
Minerva Neurosciences is cultivating an image as a psychiatry innovator by developing social rehabilitation methods for schizophrenia. The organization's overall EBITDA visualizes this trend, while the 0.00 metric confirms the current level. This momentum is based on exclusive patents and strict FDA control, while the seamless operation of research laboratories ensures adherence to clinical trial schedules.
Minerva Neurosciences, Inc. - analytical breakdowns and key metrics (NERV)
- share price and expert price forecast:
- market capitalization statistics:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Minerva Neurosciences|NERV - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Minerva Neurosciences Inc|NERV - Company Debts|Debt to Book Value Ratio Minerva Neurosciences|NERV - Company Long-Term Debts|Short-Term Debt Minerva Neurosciences|Quick Ratio minervaneurosciences.com
- earnings and market ratios statistics:
NERV - Company Net Income|Expected Net Income Minerva Neurosciences|NERV - Price to Earnings Ratio|Projected Price to Earnings Ratio minervaneurosciences.com|NERV - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Minerva Neurosciences|NERV - Operating profit EBITDA|Net earnings per share for the last 12 months Minerva Neurosciences|NERV - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months minervaneurosciences.com|NERV - Earnings growth in current year|Expected net earnings per share growth next year Minerva Neurosciences
Analysis of all company metrics:Minerva - NERV
Minerva Neurosciences specializes in developing complex psychotropic drugs for the treatment of schizophrenia, facing stringent regulatory oversight and clinical trial risks. By analyzing aggregated EBITDA, an investor assesses the actual cash flow from core operations before depreciation, taxes, and interest, which allows for the identification of the business's operational resilience and hidden disruptions in the funding of fundamental research.
Who Minerva Neurosciences competes with
BIIB: Operating profit before amortization|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACADIA Pharma - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization XENE|Profit before payment of interest, taxes and amortization VKTX|Operating profit EBITDA SUPN|Operating profit EBITDA catalystpharma.com (CPRX)|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN - Profit before payment of interest, taxes and amortization|AMLX (Amylyx Corp) - Operating profit before amortization|TRVI: Operating profit EBITDA|Profit before interest, taxes and amortization praxismedicines.com (PRAX)|Operating profit before deduction of amortization AVXL|Operating profit EBITDA CeriBell Inc|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|Omeros Corp (OMER) - Profit before interest, taxes and amortization|NGNE - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization AC Immune S.A. ACIU|VYGR: Operating profit EBITDA|Operating profit before deduction of amortization Neumora Corp|SCLX (Scilex Holding Company) - Operating profit EBITDA|tevogen.com (TVGN) - Operating income before deduction of amortization|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Inhibikase IKT|SAVA: Operating profit before amortization|Assertio Therapeutics - Operating profit EBITDA|Coya Therapeutics, Inc. (COYA) - Operating profit before deduction of amortization|VTGN: Operating profit EBITDA|Profit before interest, taxes and amortization Ovid Therapeutics (OVID)|Profit before payment of interest, taxes and amortization Acumen Pharma|CervoMed Corporation (CRVO) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|clene.com - Operating profit before amortization|Operating profit EBITDA PEPG (PepGen)|Jupiter Neurosciences, Inc. (JUNS) - Profit before interest, taxes and amortization|RLMD - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization ANVS (Annovis Bio Corporation)|GRCE (gracetx.com) - Operating profit before deduction of amortization|AIFF (fireflyneuro.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ANEW Medical|Operating profit before amortization NRSN (NeuroSense Therapeutics, Ltd.)|Operating profit EBITDA RVPH|MTVA - Profit before interest, taxes and amortization|NeurAxis, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Helius Medical Technologies, Inc. HSDT|PASG - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NEUP (Neuphoria Therapeutics Inc.)|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Addex (ADXN)|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Operating profit before deduction of amortization Cyclerion (CYCN)|Operating profit EBITDA PTIX|Operating income before deduction of amortization pasitheaclinics.com|Profit before payment of interest, taxes and amortization Cortigent CRGT|ATXI: Operating profit before amortization|Brainstorm Cell - Operating profit EBITDA|Profit before interest, taxes and amortization caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|Profit before payment of interest, taxes and amortization LBPH|Operating profit EBITDA MRNS|Operating profit EBITDA nkgenbiotech.com (NKGN)|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|TRVN (Trevena Inc) - Operating profit before amortization|VIGL: Operating profit EBITDA|Profit before interest, taxes and amortization anewmeds.com (WENA)|Operating profit before deduction of amortization CERE
